Skip to main content
Equibles
OPK logo

OPK · Opko Health, Inc.

Track OPK — free

Use OPK with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.64 +0.03 (+1.86%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$1.20B
Shares
746.33M

OPK metrics

73 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.64
Market cap
$1.20B

Price action

19 metrics
Price change (1W)
+10.8%
Price change (30D)
+24.2%
Price change (3M)
+13.9%
Price change (6M)
+39.0%
Price change (YTD)
+30.2%
Price change (1Y)
+18.8%
Trailing year
Price change (5Y)
-55.3%
52-week high
$1.69
52-week low
$1.10
Change from 52-week high
-3.0%
Change from 52-week low
+49.1%
Annualized volatility
54.4%
Beta
0.9
RSI (14D)
66.3
Price vs SMA 50
+17.5%
Price vs SMA 200
+26.6%
Avg volume (3M)
3.57M
Relative volume
0.7
Average dollar volume
$5.16M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
746.33M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.0×
reciprocal yield 48.9%
P / book
1.0
reciprocal yield 98.6%
FCF yield
-11.2%
TTM · current market cap
Buyback yield
3.9%
P / FCF
—
P / operating cash flow
—
Earnings yield
-6.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.5×
reciprocal yield 66.0%
EV / revenue historical average (5Y)
1.4×
reciprocal yield 70.5%
EV / EBIT historical average (3Y)
49.1×
reciprocal yield 2.0%
EV / EBIT historical average (5Y)
49.1×
reciprocal yield 2.0%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
17.9×
reciprocal yield 5.6%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
3.9%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-27

Profitability

9 metrics
Gross margin
40.8%
Operating margin
-8.2%
Trailing 12 months
Net margin
-12.4%
Gross profit (TTM)
$239.69M
Operating profit (TTM)
−$48.25M
Net income (TTM)
−$72.89M
Trailing 12 months
Diluted EPS (TTM)
$-0.09
FCF margin
-22.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.09

Growth

11 metrics
Revenue growth YoY
+4.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$587.90M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-4.2%
Year over year · fewer shares
Revenue CAGR (3Y)
-15.5%
Revenue CAGR (5Y)
-15.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-6.2%
Return on assets
-4.0%
Debt / equity
0.0
Current ratio
3.3
EBITDA (TTM)
$41.47M
Free cash flow (TTM)
−$134.02M
Quick ratio
2.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$300.76M
Total assets
$1.83B
Total debt
$2.69M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$123.38M
Capital expenditures (TTM)
$10.64M
R&D (TTM)
$125.22M
SG&A (TTM)
$205.85M
Stock compensation (TTM)
$10.83M
R&D / revenue
21.3%
Stock compensation / revenue
1.8%

Ownership (13F)

3 metrics
13F filers
224
13F filer change QoQ
-13
Institutional ownership
27.1%

Short interest

3 metrics
Short interest
4.5%
Latest settlement · 12.4 days to cover
Days to cover
12.4d
Short-squeeze score
76 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 944809 CUSIP 68375N103 13F (30d) 155 filings 154 filers Visit website Investor relations